On January 9, 2025, United Imaging Healthcare officially signed an agreement to significantly expand its production and office space in the Greater Houston area. The new location in Pirlan, Texas will expand the manufacturing area of the company's North American headquarters on Kirby Drive to more than three times its original size, and achieve an overall facility area growth of more than twice. The existing production facilities of Lianying Medical have only been in operation for over four years.

01. Internationalization Journey
Lianying Medical has always been committed to internationalization, and its North American journey began more than a decade ago: In 2013, United Imaging Medical established a research and development center in Houston, USA. In 2018, United Imaging Medical participated in the annual meeting of the North American Society of Radiology and entered the North American market, with Houston becoming its regional headquarters. In 2020, the North American headquarters in Houston officially opened, a nearly 100000 square foot ultra modern complex that includes United Imaging Medical's US factory, product showroom, service training center, and service parts distribution center. The CEO of North American Business Operations is Dr. Jeffrey M. Bundy. In 2022, United Imaging Medical announced the installation of its 20000th global system in New York. In May 2024, the US Food and Drug Administration (FDA) approved the United Imaging Medical uMR Jupiter 5T MRI system. This marks the first FDA approved ultra-high field MRI system for whole-body applications. It is also the first scanner to offer an 8-channel full body multi transmission system. In 2024, it announced the shipment of its 30000th system from its Houston manufacturing plant to the world for installation in the United States. We opened a research and development office in Seattle in 2024.

Since the official opening of its North American headquarters in Houston in 2020, United Imaging Medical's production in the United States has steadily increased, and all four imaging mode products currently sold have been localized in Texas. At the same time, all key spare parts have been stored in inventory points in Houston and across the United States to ensure the stability and efficiency of the supply chain.

Dr. Jeffrey M. Bundy, CEO of United Imaging Healthcare North America, said, "With the continuous growth of market demand and the continuous improvement of manufacturing capabilities, our recruitment scale is also constantly expanding." Since 2021, the company's average annual growth rate of employees in the United States has reached 60%, demonstrating its strong development momentum.

The geographical location of Houston Port provides strategic investment opportunities for United Imaging Healthcare, not only helping it expand its business in South America, but also further consolidating its position in the global market. Recently, Lianying Medical also announced its first batch of product registrations in Canada, marking another important milestone in its internationalization strategy. Since its establishment in 2011, United Imaging Medical has completed equipment installations in over 75 countries and regions worldwide, and announced earlier last summer that its 30000th device worldwide was successfully installed in the United States.

02. Outstanding performance in overseas business
As a company positioned as a world-class leader in medical innovation, Lianying Medical has achieved remarkable results in overseas markets in recent years with its industry-leading innovation advantages. According to the first half of 2024 report, the company's international market revenue reached 933 million yuan, a year-on-year increase of 29.94%, and the proportion continued to increase to 17.49%, a year-on-year increase of 3.87 percentage points. The international order volume maintained a high-speed growth trend; The product has been registered in over 13700 medical institutions in more than 70 countries and regions worldwide.

North America, as the first region for United Imaging Healthcare to embark on comprehensive globalization, remains optimistic in its performance. In the first half of 2024, the company's high-end molecular imaging product uMI Panorama successfully entered the Center for Molecular Imaging and Therapy, a leading molecular imaging and radiopharmaceutical research and treatment institution in the United States. As of now, it has covered many globally renowned universities and research institutions such as Yale University, University of California, Davis, University of Washington School of Medicine, Michigan State University Innovation Center, and State University of New York at Stony Brook.

Recently, in the third quarter 2024 report of Lianying Medical, its overseas business is also noteworthy. The report shows that its revenue for the first three quarters was approximately 6.954 billion yuan, a year-on-year decrease of 6.43%; The net profit attributable to the parent company was approximately 671 million yuan, a year-on-year decrease of 36.94%; Deducting non attributable net profit of 464 million yuan, a year-on-year decrease of 44%.

While domestic demand is under pressure, overseas business has become a highlight of Lianying Medical. In the first three quarters of 2024, the overseas business revenue reached 1.404 billion yuan, an increase of 36.49% compared to the same period last year. This significant growth is mainly due to the strong market performance of MR and MI products, as well as the international market demand stimulated by technological innovation. Overseas after-sales service revenue has achieved a doubling growth, with an increase of over 100%. The achievement of this result is attributed to the high serviceability of the company's equipment, flexible after-sales pricing strategy, and lean cost control measures. In addition, the proportion of overseas revenue in the company's total revenue has exceeded 20%, marking a milestone achievement in the company's internationalization strategy.

From the perspective of product performance and innovation breakthroughs, in some high-end equipment fields, Lianying Medical has ranked among the international first-class. As an international medical technology enterprise integrating research and development and manufacturing, Lianying Medical has significantly expanded its production and office space in the Greater Houston area, demonstrating its confidence in driving industry progress and bold change with its cutting-edge digital product portfolio.

Source: http://qixieke.com/Font/index/detailPage.html?id=3330-19